Regulation of serum 1,25(OH)2vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4

Jyothsna Gattineni, Katherine Twombley, Regina Goetz, Moosa Mohammadi, Michel Baum

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone implicated in the pathogenesis of several hypophosphatemic disorders. FGF23 causes hypophosphatemia by decreasing the expression of sodium phosphate cotransporters (NaPi-2a and NaPi-2c) and decreasing serum 1,25(OH)2Vitamin D3 levels. We previously showed that FGFR1 is the predominant receptor for the hypophosphatemic actions of FGF23 by decreasing renal NaPi-2a and 2c expression while the receptors regulating 1,25(OH)2Vitamin D3 levels remained elusive. To determine the FGFRs regulating 1,25(OH)2Vitamin D3 levels, we studied FGFR3-/-FGFR4-/- mice as these mice have shortened life span and are growth retarded similar to FGF23-/- and Klotho-/- mice. Baseline serum 1,25(OH)2Vitamin D3 levels were elevated in the FGFR3-/-FGFR4-/- mice compared with wild-type mice (102.2 ± 14.8 vs. 266.0 ± 34.0 pmol/l; P = 0.001) as were the serum levels of FGF23. Administration of recombinant FGF23 had no effect on serum 1,25(OH)2Vitamin D3 in the FGFR3-/-FGFR4-/- mice (173.4 ± 32.7 vs. 219.7 ± 56.5 pmol/l; vehicle vs. FGF23) while it reduced serum 1,25(OH)2Vitamin D3 levels in wild-type mice. Administration of FGF23 to FGFR3-/-FGFR4-/- mice resulted in a decrease in serum parathyroid hormone (PTH) levels and an increase in serum phosphorus levels mediated by increased renal phosphate reabsorption. These data indicate that FGFR3 and 4 are the receptors that regulate serum 1,25(OH)2Vitamin D3 levels in response to FGF23. In addition, when 1,25(OH)2Vitamin D3 levels are not affected by FGF23, as in FGFR3-/-FGFR4-/- mice, a reduction in PTH can override the effects of FGF23 on renal phosphate transport.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Renal Physiology
Volume301
Issue number2
DOIs
StatePublished - Aug 2011

Fingerprint

Fibroblast Growth Factor Receptors
Serum
Parathyroid Hormone
fibroblast growth factor 23
Sodium-Phosphate Cotransporter Proteins
Phosphates
Hypophosphatemia
Kidney
Phosphorus
Hormones

Keywords

  • FGF23
  • Phosphate
  • Proximal tubule

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Regulation of serum 1,25(OH)2vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. / Gattineni, Jyothsna; Twombley, Katherine; Goetz, Regina; Mohammadi, Moosa; Baum, Michel.

In: American Journal of Physiology - Renal Physiology, Vol. 301, No. 2, 08.2011.

Research output: Contribution to journalArticle

@article{d3b92f95f5a84402b27f1a46914b152e,
title = "Regulation of serum 1,25(OH)2vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4",
abstract = "Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone implicated in the pathogenesis of several hypophosphatemic disorders. FGF23 causes hypophosphatemia by decreasing the expression of sodium phosphate cotransporters (NaPi-2a and NaPi-2c) and decreasing serum 1,25(OH)2Vitamin D3 levels. We previously showed that FGFR1 is the predominant receptor for the hypophosphatemic actions of FGF23 by decreasing renal NaPi-2a and 2c expression while the receptors regulating 1,25(OH)2Vitamin D3 levels remained elusive. To determine the FGFRs regulating 1,25(OH)2Vitamin D3 levels, we studied FGFR3-/-FGFR4-/- mice as these mice have shortened life span and are growth retarded similar to FGF23-/- and Klotho-/- mice. Baseline serum 1,25(OH)2Vitamin D3 levels were elevated in the FGFR3-/-FGFR4-/- mice compared with wild-type mice (102.2 ± 14.8 vs. 266.0 ± 34.0 pmol/l; P = 0.001) as were the serum levels of FGF23. Administration of recombinant FGF23 had no effect on serum 1,25(OH)2Vitamin D3 in the FGFR3-/-FGFR4-/- mice (173.4 ± 32.7 vs. 219.7 ± 56.5 pmol/l; vehicle vs. FGF23) while it reduced serum 1,25(OH)2Vitamin D3 levels in wild-type mice. Administration of FGF23 to FGFR3-/-FGFR4-/- mice resulted in a decrease in serum parathyroid hormone (PTH) levels and an increase in serum phosphorus levels mediated by increased renal phosphate reabsorption. These data indicate that FGFR3 and 4 are the receptors that regulate serum 1,25(OH)2Vitamin D3 levels in response to FGF23. In addition, when 1,25(OH)2Vitamin D3 levels are not affected by FGF23, as in FGFR3-/-FGFR4-/- mice, a reduction in PTH can override the effects of FGF23 on renal phosphate transport.",
keywords = "FGF23, Phosphate, Proximal tubule",
author = "Jyothsna Gattineni and Katherine Twombley and Regina Goetz and Moosa Mohammadi and Michel Baum",
year = "2011",
month = "8",
doi = "10.1152/ajprenal.00740.2010",
language = "English (US)",
volume = "301",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Regulation of serum 1,25(OH)2vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4

AU - Gattineni, Jyothsna

AU - Twombley, Katherine

AU - Goetz, Regina

AU - Mohammadi, Moosa

AU - Baum, Michel

PY - 2011/8

Y1 - 2011/8

N2 - Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone implicated in the pathogenesis of several hypophosphatemic disorders. FGF23 causes hypophosphatemia by decreasing the expression of sodium phosphate cotransporters (NaPi-2a and NaPi-2c) and decreasing serum 1,25(OH)2Vitamin D3 levels. We previously showed that FGFR1 is the predominant receptor for the hypophosphatemic actions of FGF23 by decreasing renal NaPi-2a and 2c expression while the receptors regulating 1,25(OH)2Vitamin D3 levels remained elusive. To determine the FGFRs regulating 1,25(OH)2Vitamin D3 levels, we studied FGFR3-/-FGFR4-/- mice as these mice have shortened life span and are growth retarded similar to FGF23-/- and Klotho-/- mice. Baseline serum 1,25(OH)2Vitamin D3 levels were elevated in the FGFR3-/-FGFR4-/- mice compared with wild-type mice (102.2 ± 14.8 vs. 266.0 ± 34.0 pmol/l; P = 0.001) as were the serum levels of FGF23. Administration of recombinant FGF23 had no effect on serum 1,25(OH)2Vitamin D3 in the FGFR3-/-FGFR4-/- mice (173.4 ± 32.7 vs. 219.7 ± 56.5 pmol/l; vehicle vs. FGF23) while it reduced serum 1,25(OH)2Vitamin D3 levels in wild-type mice. Administration of FGF23 to FGFR3-/-FGFR4-/- mice resulted in a decrease in serum parathyroid hormone (PTH) levels and an increase in serum phosphorus levels mediated by increased renal phosphate reabsorption. These data indicate that FGFR3 and 4 are the receptors that regulate serum 1,25(OH)2Vitamin D3 levels in response to FGF23. In addition, when 1,25(OH)2Vitamin D3 levels are not affected by FGF23, as in FGFR3-/-FGFR4-/- mice, a reduction in PTH can override the effects of FGF23 on renal phosphate transport.

AB - Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone implicated in the pathogenesis of several hypophosphatemic disorders. FGF23 causes hypophosphatemia by decreasing the expression of sodium phosphate cotransporters (NaPi-2a and NaPi-2c) and decreasing serum 1,25(OH)2Vitamin D3 levels. We previously showed that FGFR1 is the predominant receptor for the hypophosphatemic actions of FGF23 by decreasing renal NaPi-2a and 2c expression while the receptors regulating 1,25(OH)2Vitamin D3 levels remained elusive. To determine the FGFRs regulating 1,25(OH)2Vitamin D3 levels, we studied FGFR3-/-FGFR4-/- mice as these mice have shortened life span and are growth retarded similar to FGF23-/- and Klotho-/- mice. Baseline serum 1,25(OH)2Vitamin D3 levels were elevated in the FGFR3-/-FGFR4-/- mice compared with wild-type mice (102.2 ± 14.8 vs. 266.0 ± 34.0 pmol/l; P = 0.001) as were the serum levels of FGF23. Administration of recombinant FGF23 had no effect on serum 1,25(OH)2Vitamin D3 in the FGFR3-/-FGFR4-/- mice (173.4 ± 32.7 vs. 219.7 ± 56.5 pmol/l; vehicle vs. FGF23) while it reduced serum 1,25(OH)2Vitamin D3 levels in wild-type mice. Administration of FGF23 to FGFR3-/-FGFR4-/- mice resulted in a decrease in serum parathyroid hormone (PTH) levels and an increase in serum phosphorus levels mediated by increased renal phosphate reabsorption. These data indicate that FGFR3 and 4 are the receptors that regulate serum 1,25(OH)2Vitamin D3 levels in response to FGF23. In addition, when 1,25(OH)2Vitamin D3 levels are not affected by FGF23, as in FGFR3-/-FGFR4-/- mice, a reduction in PTH can override the effects of FGF23 on renal phosphate transport.

KW - FGF23

KW - Phosphate

KW - Proximal tubule

UR - http://www.scopus.com/inward/record.url?scp=79961141521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961141521&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00740.2010

DO - 10.1152/ajprenal.00740.2010

M3 - Article

VL - 301

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2

ER -